Healthcare Reforms Under the IRA: Expanding Access to Care
Healthcare Law Blog
AUGUST 25, 2022
Fifteen more Part D drugs are set to be published in 2027, followed by 15 Part D and Part B drugs, collectively, in 2028. Drugs eligible for negotiation must be FDA-approved for at least 7 years and marketed in conformance with the Federal Food, Drug, and Cosmetic Act. Program Compliance. Negotiation-Eligible Drugs.
52 
Let's personalize your content